ORIGIN MATERIALS INC (ORGN)
US68622D1063 - Common Stock
We assign a fundamental rating of 2 out of 10 to ORGN. ORGN was compared to 83 industry peers in the Chemicals industry. The financial health of ORGN is average, but there are quite some concerns on its profitability. ORGN does not seem to be growing, but still is valued expensively.
1. Profitability
1.1 Basic Checks
ORGN had negative earnings in the past year.
ORGN had a negative operating cash flow in the past year.
In multiple years ORGN reported negative net income over the last 5 years.
ORGN had a negative operating cash flow in each of the past 5 years.
1.2 Ratios
Looking at the Return On Assets, with a value of -20.18%, ORGN is doing worse than 90.36% of the companies in the same industry.
ORGN has a Return On Equity of -22.46%. This is amonst the worse of the industry: ORGN underperforms 83.13% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -20.18% | ||
| ROE | -22.46% | ||
| ROIC | N/A |
ROA(3y)9.77%
ROA(5y)N/A
ROE(3y)13.45%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
Looking at the Gross Margin, with a value of 11.37%, ORGN is doing worse than 80.72% of the companies in the same industry.
ORGN does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 11.37% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
ORGN does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, ORGN has more shares outstanding
ORGN has a better debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 1.96 indicates that ORGN is not a great score, but indicates only limited risk for bankruptcy at the moment.
ORGN's Altman-Z score of 1.96 is in line compared to the rest of the industry. ORGN outperforms 54.22% of its industry peers.
ORGN has a Debt/Equity ratio of 0.02. This is a healthy value indicating a solid balance between debt and equity.
ORGN has a better Debt to Equity ratio (0.02) than 92.77% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.02 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 1.96 |
ROIC/WACCN/A
WACC9.02%
2.3 Liquidity
A Current Ratio of 16.27 indicates that ORGN has no problem at all paying its short term obligations.
The Current ratio of ORGN (16.27) is better than 100.00% of its industry peers.
A Quick Ratio of 16.16 indicates that ORGN has no problem at all paying its short term obligations.
Looking at the Quick ratio, with a value of 16.16, ORGN belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 16.27 | ||
| Quick Ratio | 16.16 |
3. Growth
3.1 Past
The earnings per share for ORGN have decreased strongly by -231.43% in the last year.
The Revenue has grown by 123.14% in the past year. This is a very strong growth!
EPS 1Y (TTM)-231.43%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-168.18%
Revenue 1Y (TTM)123.14%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%14.87%
3.2 Future
ORGN is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -20.21% yearly.
Based on estimates for the next years, ORGN will show a very strong growth in Revenue. The Revenue will grow by 67.78% on average per year.
EPS Next Y-460%
EPS Next 2Y-111.19%
EPS Next 3Y-38.56%
EPS Next 5Y-20.21%
Revenue Next Year11.22%
Revenue Next 2Y41.59%
Revenue Next 3Y35.53%
Revenue Next 5Y67.78%
3.3 Evolution
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for ORGN. In the last year negative earnings were reported.
Also next year ORGN is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
A cheap valuation may be justified as ORGN's earnings are expected to decrease with -38.56% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-111.19%
EPS Next 3Y-38.56%
5. Dividend
5.1 Amount
No dividends for ORGN!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
ORIGIN MATERIALS INC
NASDAQ:ORGN (12/20/2024, 8:00:02 PM)
After market: 1.03 +0.04 (+4.18%)0.9887
+0.02 (+1.93%)
Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)
Earnings (Next)
Inst Owners18.2%
Inst Owner Change-0.21%
Ins Owners14.74%
Ins Owner Change-0.15%
Market Cap144.60M
Analysts85
Price Target3.83 (287.38%)
Short Float %4.37%
Short Ratio4.94
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-24.03%
Min EPS beat(2)-33.69%
Max EPS beat(2)-14.38%
EPS beat(4)2
Avg EPS beat(4)1.22%
Min EPS beat(4)-33.69%
Max EPS beat(4)50.98%
EPS beat(8)6
Avg EPS beat(8)89.63%
EPS beat(12)10
Avg EPS beat(12)150.97%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)37.06%
Min Revenue beat(2)-3.12%
Max Revenue beat(2)77.24%
Revenue beat(4)3
Avg Revenue beat(4)21.03%
Min Revenue beat(4)-3.12%
Max Revenue beat(4)77.24%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-6.25%
EPS NQ rev (1m)0%
EPS NQ rev (3m)8.33%
EPS NY rev (1m)-33.33%
EPS NY rev (3m)-33.33%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)-0.32%
Revenue NY rev (3m)-0.32%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 4.12 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 0.4 | ||
| P/tB | 0.4 | ||
| EV/EBITDA | N/A |
EPS(TTM)-0.46
EYN/A
EPS(NY)-0.42
Fwd EYN/A
FCF(TTM)-0.52
FCFYN/A
OCF(TTM)-0.4
OCFYN/A
SpS0.24
BVpS2.45
TBVpS2.45
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -20.18% | ||
| ROE | -22.46% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 11.37% | ||
| FCFM | N/A |
ROA(3y)9.77%
ROA(5y)N/A
ROE(3y)13.45%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.09
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.02 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 167.77% | ||
| Cap/Sales | 48.96% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 16.27 | ||
| Quick Ratio | 16.16 | ||
| Altman-Z | 1.96 |
F-Score4
WACC9.02%
ROIC/WACCN/A
Cap/Depr(3y)5723.46%
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-231.43%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-168.18%
EPS Next Y-460%
EPS Next 2Y-111.19%
EPS Next 3Y-38.56%
EPS Next 5Y-20.21%
Revenue 1Y (TTM)123.14%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%14.87%
Revenue Next Year11.22%
Revenue Next 2Y41.59%
Revenue Next 3Y35.53%
Revenue Next 5Y67.78%
EBIT growth 1Y-34.81%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year12.51%
EBIT Next 3Y9.01%
EBIT Next 5Y22.39%
FCF growth 1Y6.13%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-271.71%
OCF growth 3YN/A
OCF growth 5YN/A